---
$id: https://graph.org.ai/products/commodity/51183307
$type: Product
source: UNSPSC
code: "51183307"
title: "Saxagliptin hydrochloride"
class: "51183300"
classTitle: "Antidiabetic and hyperglycemic dipeptidyl peptidase-4 inhibitors"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Saxagliptin hydrochloride

**UNSPSC Code**: 51183307
**Class**: [Antidiabetic and hyperglycemic dipeptidyl peptidase-4 inhibitors](Antidiabetic and hyperglycemic dipeptidyl peptidase-4 inhibitors.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a protease inhibitor and anti-diabetic agent with the molecular formula C18H25N3O2.CLH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z8J84YIX6L. European Medicines Agency schedules saxagliptin hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB30804. The term saxagliptin hydrochloride is a U.S. FDA designation. Most nations, for tariff and trade purposes, schedule saxagliptin hydrochloride under HS 29339990 and SITC 51577. As of Q4 2014, SAXAGLIPTIN HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Saxagliptin hydrochloride bears US NLM identifiers UMLS ID C2719771 and NCI Concept Code C81702. SMILES: C1[C@@H]2C[C@@H]2N([C@@H]1C#N)C(=O)[C@H]([C@]34C[C@@H]5CC(C3)C[C@@](C5)(C4)O)N.CL.

